Skip to content

Twelve Month Clinical Evaluation of KeraSoft IC Soft Contact Lenses

Twelve Month Clinical Evaluation of KeraSoft IC Soft Contact Lenses

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01416272
Enrollment
12
Registered
2011-08-15
Start date
2011-04-30
Completion date
2013-02-28
Last updated
2014-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keratoconus

Brief summary

The objective of this twelve month dispensing study is to evaluate the clinical performance, particularly comfort and vision, of KeraSoft IC Soft Contact Lenses.

Interventions

DEVICEKeraSoft IC Soft Contact Lenses

Lenses will be worn between 8 and 16 hrs each day, for 12 months

Sponsors

Bausch & Lomb Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have participated and completed a previous study (ROC2-10-078). * Is Keratoconic

Exclusion criteria

* Has any systemic disease affecting ocular health. * Is using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance. * Is not correctable to 20/50 or better in each eye with contact lenses. * Has greater than Grade 2 slit lamp exam findings. * Has any atypical scar for a keratoconic or neovascularization within the central 4mm of the cornea. Subjects with minor peripheral corneal scarring that, in the Investigator's judgment, does not interfere with contact lens wear are eligible for this study. * Has any neovascularization within the central 4mm of the cornea.

Design outcomes

Primary

MeasureTime frameDescription
Comfort4 visits over 1 yearSymptoms and complaints measured on an analog scale

Secondary

MeasureTime frameDescription
Visual Acuity - Low Contrast4 visits over 1 yearLow contrast visual acuity measured with high ambient illumination (LCHI)
Visual Acuity - High Contrast4 visits over 1 yearHigh contrast visual acuity measured with high ambient illumination (HCHI)

Countries

United States

Participant flow

Participants by arm

ArmCount
KeraSoft IC Soft Contact Lenses
KeraSoft IC Soft Contact Lenses, with CIBA Clear Care solution provided for lens care KeraSoft IC Soft Contact Lenses: Lenses will be worn between 8 and 16 hrs each day, for 12 months
12
Total12

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up1
Overall StudyStudy related complaints1
Overall StudyUnacceptable distance visual acuity2

Baseline characteristics

CharacteristicKeraSoft IC Soft Contact Lenses
Age, Continuous48 years
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
7 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 12
serious
Total, serious adverse events
0 / 12

Outcome results

Primary

Comfort

Symptoms and complaints measured on an analog scale

Time frame: 4 visits over 1 year

Population: DUE TO THE CANCELLATION OF THIS PROJECT, NO STATISTICAL OR CLINICALLY MEANINGFUL CONCLUSIONS RELATED TO THE STUDY ENDPOINTS WERE MADE.

Secondary

Visual Acuity - High Contrast

High contrast visual acuity measured with high ambient illumination (HCHI)

Time frame: 4 visits over 1 year

Population: DUE TO THE CANCELLATION OF THIS PROJECT, NO STATISTICAL OR CLINICALLY MEANINGFUL CONCLUSIONS RELATED TO THE STUDY ENDPOINTS WERE MADE.

Secondary

Visual Acuity - Low Contrast

Low contrast visual acuity measured with high ambient illumination (LCHI)

Time frame: 4 visits over 1 year

Population: DUE TO THE CANCELLATION OF THIS PROJECT, NO STATISTICAL OR CLINICALLY MEANINGFUL CONCLUSIONS RELATED TO THE STUDY ENDPOINTS WERE MADE.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026